Literature DB >> 11986108

Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.

Alice Song1, Ingrid U Scott, Harry W Flynn, Donald L Budenz.   

Abstract

OBJECTIVE: To investigate clinical factors, causative organisms, treatments, and visual acuity and intraocular pressure outcomes associated with delayed-onset, bleb-associated endophthalmitis.
DESIGN: Retrospective, noncomparative, consecutive case series. PARTICIPANTS: All patients treated for bleb-associated endophthalmitis at Bascom Palmer Eye Institute between January 1, 1996, and July 1, 2001. All patients had prior glaucoma filtering surgery. Patients with inadvertent functioning blebs after cataract extraction were excluded. MAIN OUTCOME MEASURES: Visual acuity outcomes and intraocular pressure control after endophthalmitis.
RESULTS: An antifibrotic agent was used in 40 (82%) of the 49 eyes identified, including mitomycin-C in 33 (67%) and 5-fluorouracil (5-FU) in 7 (14%). The mean interval between the initial filtering surgery and endophthalmitis diagnosis was 5.0 years (range, 0.7-12.2 years). The mean follow-up time after treatment for endophthalmitis was 6.9 months (range, 1-60 months). As recorded in the medical record, potential risk factors and clinical features among the study population included history of bleb leak in 13 (27%) eyes, bleb manipulations in 15 (31%) (needling in 3 [6%], compression sutures in 2 [4%], laser suture lysis in 6 [12%], bleb revision in 5 [10%], and autologous blood injection in 2 [4%]), bleb defects in 6 (12%), inferior bleb location 6 (12%), and nasolacrimal duct obstruction in 1 (2%). The most common causative organisms were Streptococcus species in 15 eyes (31%) and Staphylococcus species in 11 eyes (22%). Final visual acuities in the vitrectomy group (n = 22) versus the initial tap group (n = 26) were as follows: > or = 20/40 (5% versus 15%), 20/50 to 20/400 (32% versus 54%), and < 5/200 (64% versus 31%). Eleven (22%) patients eventually underwent enucleation or evisceration secondary to pain and/or poor vision (light perception to no light perception). In 4 (11%) of the 38 eyes not enucleated, intraocular pressures were poorly controlled at last follow-up (>21 mmHg) after treatment of endophthalmitis.
CONCLUSIONS: Streptococcus species and Staphylococcus species were the most common causative organisms in the current series of patients with delayed-onset bleb-associated endophthalmitis. Despite successful treatment of the infection, visual outcomes are generally poor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986108     DOI: 10.1016/s0161-6420(02)00965-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  38 in total

1.  Comparison of fornix- and limbus-based conjunctival flaps in mitomycin C trabeculectomy with laser suture lysis in Japanese glaucoma patients.

Authors:  Takeo Fukuchi; Jun Ueda; Kiyoshi Yaoeda; Kieko Suda; Masaaki Seki; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

2.  Persistent hypotony after trabeculectomy: incidence and associated factors in the Collaborative Bleb-Related Infection Incidence and Treatment Study.

Authors:  Tomomi Higashide; Shinji Ohkubo; Yosuke Sugimoto; Yoshiaki Kiuchi; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2016-05-13       Impact factor: 2.447

3.  Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.

Authors:  Ajay E Kuriyan; Kathleen D Weiss; Harry W Flynn; William E Smiddy; Audina M Berrocal; Thomas A Albini; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2014-01-10       Impact factor: 5.258

4.  Intraocular lens implantation and vitrectomy using 0.025% povidone-iodine in irrigation solution for bleb-related endophthalmitis.

Authors:  Yorihisa Kitagawa; Hiroyuki Shimada; Hiroyuki Nakashizuka; Takayuki Hattori; Yoshio Yamazaki
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

Review 5.  Endophthalmitis: Then and Now.

Authors:  Nidhi Relhan; Richard K Forster; Harry W Flynn
Journal:  Am J Ophthalmol       Date:  2017-12-05       Impact factor: 5.258

6.  Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.

Authors:  Seenu M Hariprasad; William E Mieler; Gaurav K Shah; Kevin J Blinder; Rajendra S Apte; Nancy M Holekamp; Matthew A Thomas; Jingduan Chi; Randall A Prince
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography.

Authors:  Kei-Ichi Nakashima; Toshihiro Inoue; Ayako Fukushima; Saori Hirakawa; Sachi Kojima; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-09       Impact factor: 3.117

8.  Bleb-related Endophthalmitis: Clinical Presentation, Isolates, Treatment and Visual Outcome of Culture-proven Cases.

Authors:  Basel T Ba'arah; William E Smiddy
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

9.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

Review 10.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.